Articles On Creso Pharma (ASX:CPH)

Creso Pharma (ASX: CPH) is looking to tap into the emerging psychedelics medicine market with the proposed acquisition of Canadian company Halucenex worth more than $7 million. If successful, the deal would give Creso a foothold in the gr...

Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of...

Once again, medicinal cannabis company Creso Pharma (ASX: CPH) keeps pleasantly surprising us. Today they have REALLY surprised us by announcing they have acquired a Psychedelics company.

Special Report: Creso Pharma provides shareholders additional background on its recent acquisition of Canadian psychedelics company, Halucenex Life Sciences Inc. ... Read More The post Creso Pharma Q&A: Halucenex Life Sciences acquisiti...

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed an agreement to acquire Halucenex Life Sciences Inc. (Halucenex), an established psychedelics company focused on developing treatments for Treatment Resistant Depression in individuals suff...

Medical marijuana company Creso Pharma (ASX:CPH) has just entered the emerging $100 billion global market for psychedelic medicine with acquisition ... Read More The post Creso Pharma’s acquisition of Halucenex Life Sciences marks the first...

Special Report: Medical marijuana company Creso Pharma (ASX:CPH) has just entered the emerging $100 billion global market for psychedelic medicine ... Read More The post Creso Pharma enters psychedelics market with ‘transformational’ Canadi...

The Creso Pharma Ltd (ASX: CPH) share price has been up and down today following a signed letter of intent (LOI) with ImpACTIVE. At the time of writing, Creso shares are down 2.5% to 20 cents in late afternoon trade, after earlier peaking...

Today, Creso Pharma Limited (ASX:CPH, FRA:1X8) announced a Letter of Interest (LOI) which marks its entry into the CBD market for sport and recreation; an industry whose global valuation is estimated at US$22BN by 2022 and C$220M in Canada...

Source:JacobLund,Shutterstock Summary Creso Pharma enters into a commercial agreement with a US-based distribution company for anibidiol®. The agreement provides major market opportunity to Creso with significant growth anticipated....

Creso Pharma (ASX: CPH) just released its preliminary financial reports for the year, which as expected show a bunch of impairments, debt clean ups and other scary looking one off costs that come with a balance sheet clean up - these are al...

Creso Pharma (ASX: CPH | FRA: 1X8) is set to distribute its range of CBD and hemp animal health anibidiol® products throughout the US, following a deal signed with CERES Natural Remedies.

CERES is a leading provider of plant-based medicines and CBD products with an established distribution footprint of around 50,000 outlets in the US focusing on high growth customer segments.

In a commercially material development for Creso Pharma Limited (ASX:CPH, FRA:1X8), the company has executed a non-binding letter of intent (LOI) with leading CBD and plant-based medicines provider CERES Natural Remedies (CERES) (www.ceresr...

Special Report: Creso Pharma (ASX:CPH) has announced plans for its hemp and CBD-based animal health products to be distributed in ... Read More The post Creso Pharma makes plans to enter US market with new partnership appeared first on Stoc...

Creso Pharma Limited (ASX:CPH, FRA: 1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$5...

Summary ASX-listed global medicinal cannabis developer Creso Pharma has secured four new purchase orders for its leading Ritual Green product range. The cannabis player anticipates further POs that will include the recently-launched Bl...

The company also has several growth initiatives pending, including the launch of its pre-roll joint range and entry into the emerging hash market.

At time of writing, the share price of Creso Pharma Ltd [ASX:CPH] is up more than 6%, trading at 24 cents. You can see the CPH share price bouncing off a level below before pushing higher again... The post Creso Pharma Share Price up Again...

The target markets include Cambodia, Afghanistan, Azerbaijan, Bangladesh, Georgia, the Maldives, Myanmar, Tajikistan, Turkmenistan, Uzbekistan and Vietnam, which takes the potential addressable market to 750 million. 

Special Report: Creso Pharma (ASX:CPH) has signed a distribution agreement that will see its hemp derived products sold in the ... Read More The post Creso Pharma enters vast new market with $2.5 million distribution agreement appeared firs...

The Creso Pharma Ltd (ASX: CPH) share price has been a strong performer on Monday morning. At one stage today, the cannabis company’s shares were up as much as 11% to 25 cents. The Creso Pharma share price has since pulled back a touch but...

Creso Pharma Limited’s (ASX:CPH; FRA: 1X8) strong performance over the last three months - during which time its share price has surged more than 500% - may be set to continue with the negotiation of a comprehensive distribution agreement w...

Special Report: The founder of the world’s biggest cannabis company has explained what he sees in a leading Australian player. ... Read More The post Famed cannabis entrepreneur Bruce Linton explains what he sees in Creso Pharma appeared fi...

Long term Creso Pharma (ASX: CPH) shareholders have had a rough ride in the last 12 months. Last week the $20M capped CPH raised circa A$9M at $0.0291 per share, finally extinguishing the company’s debt and ridding the company of major con...

We put out a short note on Creso Pharma (ASX: CPH) to some of you that might have previously invested in the stock and not had a positive experience. After a couple of false starts, our plan is to ride this momentum over the coming weeks an...

Summary Australian cannabis player Creso Pharma has brought the marketing and sales function of cannaQIX® in-house. The Company will directly supply its product to all major wholesalers in Australia. With its in-house functions, Creso...

The Creso Pharma Ltd (ASX: CPH) share price has been a poor performer on Monday. At one stage today the cannabis company’s shares were down almost 5% to 20 cents. The Creso Pharma share price has since recovered a touch but is still down 2...

In afternoon trade on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. At the time of writing, the benchmark index is up 0.6% to 6,880.2 points. Fours ASX shares that have failed to follow the...

With cannaQIX sales taking off, Creso Pharma (ASX:CPH) is taking steps to improve margins on the cannabis lozenges by bringing ... Read More The post Creso Pharma brings marketing and sales of CannaQIX cannabis lozenge in-house appeared fir...

By bringing this function inhouse, Creso is able to improve profit margins for cannaQIX® and can set the stage for further product extensions and new product launches such as cannaDOL® in Switzerland.

Creso Pharma Limited (ASX:CPH, FRA: 1X8) has excelled in the last month in terms of sales and orders for its products, and today the company announced that it is taking over the marketing and sales strategy for cannaQIX®, an initiative that...

In the quarter to December 2020, there were a number of significant shifts in the regulatory environment, which have the capacity to unlock a number of near-term and medium-term openings.

–The below is a company-sponsored announcement– Momentum for cannabis stocks continues to intensify, as international acceptance instils confidence in companies to develop and distribute legal products. The confidence in the market was hi...

Summary Global cannabis company Creso Pharma has secured four new purchase orders in Canada. The new order with Cannabis NB marks Mernova’s entry into the Canadian province. The Company expects the launch of Black Mamba to be as well-...

Shares in ASX-listed cannabis company Creso Pharma Ltd (ASX: CPH) are on a wobbly ride this morning. After lifting to a high of 22.5 cents in early trade, the Creso Pharma share price rollercoastered back to its opening price of 21 cents....

New Brunswick is an important market and provides another opportunity for the company to grow its revenue streams.

Special Report: Creso Pharma (ASX:CPH)’s Canadian subsidiary has moved into yet another market – and unveiled another product in its ... Read More The post Creso Pharma’s Canadian cannabis subsidiary picking up speed with more purchase orde...

Creso Pharma Limited (ASX:CPH; FRA: 1X8) continues to consolidate its leadership position in being one of the few ASX-listed companies in the cannabis sector that are generating material revenues. Investors who took a stake in Creso Pharma...

At time of writing, the share price of Creso Pharma Ltd [ASX:CPH] is up more than 10%, trading at 21.5 cents. Here’s the how the last five years played out for the CPH share price. From a high in late 2017, CPH was caught in a savage... The...

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) has fought back from a sizeable morning decline and is climbing higher. At the time of writing, the benchmark is up 0.2% to 6,617 points. Four ASX shares that have not let that...

Special Report: Cannabis company Creso Pharma (ASX:CPH) is welcoming a big shift in how Australia regulates CBD oil. As of ... Read More The post Creso Pharma cheers as Australia allows over-the-counter CBD oil sales appeared first on Stock...

The Creso Pharma Ltd (ASX: CPH) share price has started the week with a bang. At the time of writing, the cannabis company’s shares are up 18% to 23 cents. Why is the Creso Pharma share price rocketing higher? Investors have been buying Cr...

The move by the TGA to down-schedule low-dose CBD preparations unlocks a market estimated to exceed $200 million per annum.

Creso Pharma Limited (ASX:CPH; FRA: 1X8) will hit the ground running today as over-the-counter (OTC) sales of low-dose cannabidiol (CBD) products in Australian pharmacies commences. The sale of low-dose CBD products was made possible follow...

After an impressive performance in the December quarter of 2020, shares in Creso Pharma Limited (ASX:CPH; FRA:1X8) looks set to start the year on a strong note based on management’s commentary in its quarterly report released on Friday morn...

Australia has one of the highest rates of household pet ownership in the world. The RSPCA estimates 61 per cent of Australian households own pets and all up there are over 29 million pets across the country. The most common domesticated an...

At time of writing the Creso Pharma Ltd [ASX:CPH] share price is trading at 24.2 cents, up 10%. Creso Pharma recently announced a record start for financial year 2021. Creso Pharma is a medicinal cannabis company that brings pharmaceutical....

Summary Creso Pharma has received a repeat purchase order for its animal health products range, anibidiol® valued at A$247,826 from Virbac Switzerland. The new purchase order adds to the strong demand for its products across Europe, La...

Beginning the year with healthy purchase orders is a major achievement for the company and highlights the growing demand for its leading product ranges on a global scale.